Editorial: STAT-4 polymorphism - a tool to personalise clinical practice in chronic HBV infection. Authors' reply

Aliment Pharmacol Ther. 2018 Oct;48(7):769-770. doi: 10.1111/apt.14940.

Authors

Rasha El Sharkawy¹, Jacob George¹, Mohammed Eslam¹

Affiliation

¹ Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, NSW, Australia.

PMID: 30246306
DOI: 10.1111/apt.14940

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Hepatitis B virus
Hepatitis B, Chronic*
Humans
Liver Cirrhosis*
Polymorphism, Genetic
STAT4 Transcription Factor

Substances

STAT4 Transcription Factor
STAT4 protein, human